Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  28 results for ""Tocilizumab""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial.

  • Source: Infectious Diseases & Clinical Microbiology (IDCM). Jun2022, Vol. 4 Issue 2, p127-132. 6p.

Record details

×
Academic Journal

Efficacy of Tocilizumab in COVID-19: Single-Center Experience.

  • Authors : Kaya S; Department of Infectious Diseases, Gazi Yaşargil Training and Research Hospital, University of Health Sciences, Diyarbakir, Turkey.; Kavak S

Subjects: COVID-19 Drug Treatment*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Cytokine Release Syndrome/Cytokine Release Syndrome/Cytokine Release Syndrome/*drug therapy

  • Source: BioMed research international [Biomed Res Int] 2021 Dec 30; Vol. 2021, pp. 1934685. Date of Electronic Publication: 2021 Dec 30 (Print Publication: 2021).Publisher: Wiley Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141

Record details

×
Academic Journal

A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy.

  • Source: International Journal of Rheumatic Diseases. Sep2020, Vol. 23 Issue 9, p1210-1218. 9p.

Record details

×
Academic Journal

The sharp edge of immunosuppressive treatments: infections.

  • Authors : Özşahin A; Department of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, Turkiye.; Ilgar T

Subjects: Interleukin 1 Receptor Antagonist Protein*/Interleukin 1 Receptor Antagonist Protein*/Interleukin 1 Receptor Antagonist Protein*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Turkish journal of medical sciences [Turk J Med Sci] 2024 May 07; Vol. 54 (4), pp. 752-760. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID:

Record details

×
  • 1-10 of  28 results for ""Tocilizumab""